These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9399658)

  • 1. Heterogeneous p53 mutations in a Burkitt lymphoma from an AIDS patient with monoclonal c-myc and VDJ rearrangements.
    Campomenosi P; Fronza G; Ottaggio L; Roncella S; Inga A; Bogliolo M; Monti P; Assereto P; Moro F; Cutrona G; Bozzo S; Chiorazzi N; Abbondandolo A; Ferrarini M
    Int J Cancer; 1997 Dec; 73(6):816-21. PubMed ID: 9399658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: implications for lymphomagenesis in acquired immunodeficiency syndrome.
    Roncella S; Cutrona G; Favre A; Ulivi M; Fais F; Signorini A; Grossi CE; Chiorazzi N; Ferrarini M
    Blood; 1996 Jul; 88(2):599-608. PubMed ID: 8695808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma.
    Gutiérrez MI; Bhatia K; Cherney B; Capello D; Gaidano G; Magrath I
    Ann Oncol; 1997 Oct; 8(10):987-94. PubMed ID: 9402172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic rearrangement of C-MYC oncogene occurs prior to infection with Epstein-Barr virus in the monoclonal malignant B cells from an AIDS patient.
    Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Landonio G; Foà R; Rowe M; Ferrarini M
    Leuk Lymphoma; 1993 Jan; 9(1-2):157-64. PubMed ID: 8386576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma.
    Zunino A; Viaggi S; Ottaggio L; Fronza G; Schenone A; Roncella S; Abbondandolo A
    Haematologica; 2000 Mar; 85(3):250-5. PubMed ID: 10702812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma.
    Jain R; Roncella S; Hashimoto S; Carbone A; Francia di Celle P; Foa R; Ferrarini M; Chiorazzi N
    J Immunol; 1994 Jul; 153(1):45-52. PubMed ID: 8207254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of the p53 protein in AIDS-related non-Hodgkin's lymphomas and polymorphic lymphoproliferations.
    Martin A; Flaman JM; Frebourg T; Davi F; El Mansouri S; Amouroux J; Raphaël M
    Br J Haematol; 1998 May; 101(2):311-7. PubMed ID: 9609527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absence of ongoing immunoglobulin gene hypermutation suggests a distinct mechanism for c-myc mutation in endemic Burkitt's lymphoma.
    Cowley CG; Carroll WL; Johnston JM
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):29-35. PubMed ID: 8556366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topological organization of the MYC/IGK locus in Burkitt's lymphoma cells assessed by nuclear halo preparations.
    Rätsch A; Joos S; Kioschis P; Lichter P
    Exp Cell Res; 2002 Feb; 273(1):12-20. PubMed ID: 11795942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma.
    Fais F; Fronza G; Roncella S; Inga A; Campomenosi P; Cutrona G; Pezzolo A; Fedeli F; Abbondandolo A; Chiorazzi N; Pistoia V; Ferrarini M
    Int J Cancer; 2000 Dec; 88(5):744-50. PubMed ID: 11072243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
    Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
    Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.
    Ballerini P; Gaidano G; Gong JZ; Tassi V; Saglio G; Knowles DM; Dalla-Favera R
    Blood; 1993 Jan; 81(1):166-76. PubMed ID: 8380252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53.
    Ramqvist T; Magnusson KP; Wang Y; Szekely L; Klein G; Wiman KG
    Oncogene; 1993 Jun; 8(6):1495-500. PubMed ID: 8502475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
    Preudhomme C; Dervite I; Wattel E; Vanrumbeke M; Flactif M; Lai JL; Hecquet B; Coppin MC; Nelken B; Gosselin B
    J Clin Oncol; 1995 Apr; 13(4):812-20. PubMed ID: 7707106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
    Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
    J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
    Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
    Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
    Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
    Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.
    Clark HM; Yano T; Otsuki T; Jaffe ES; Shibata D; Raffeld M
    Cancer Res; 1994 Jul; 54(13):3383-6. PubMed ID: 8012955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L; Groudine M
    Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.